These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29934845)

  • 1. Executive dysfunctions differentially predict amotivation in first-episode schizophrenia-spectrum disorder: a prospective 1-year follow-up study.
    Chang WC; Liu JTT; Hui CLM; Chan SKW; Lee EHM; Suen YN; Chen EYH
    Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):887-896. PubMed ID: 29934845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of motivational impairment: 12-month follow-up of the randomized-controlled trial on extended early intervention for first-episode psychosis.
    Chang WC; Kwong VW; Chan GH; Jim OT; Lau ES; Hui CL; Chan SK; Lee EH; Chen EY
    Eur Psychiatry; 2017 Mar; 41():37-41. PubMed ID: 28049079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amotivation and functional outcomes in early schizophrenia.
    Fervaha G; Foussias G; Agid O; Remington G
    Psychiatry Res; 2013 Dec; 210(2):665-8. PubMed ID: 23911005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinic of apathy in schizophrenia: a critical review of the issue].
    Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
    Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of avolition and cognitive impairment on functional outcome in first-episode schizophrenia-spectrum disorder: a prospective one-year follow-up study.
    Chang WC; Hui CL; Chan SK; Lee EH; Chen EY
    Schizophr Res; 2016 Feb; 170(2-3):318-21. PubMed ID: 26778673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial.
    Favrod J; Nguyen A; Chaix J; Pellet J; Frobert L; Fankhauser C; Ismailaj A; Brana A; Tamic G; Suter C; Rexhaj S; Golay P; Bonsack C
    Psychother Psychosom; 2019; 88(2):84-95. PubMed ID: 30783071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia.
    Fervaha G; Foussias G; Agid O; Remington G
    Acta Psychiatr Scand; 2014 Oct; 130(4):290-9. PubMed ID: 24850369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive deficits and its relation with psychopathology and global functioning in first episode schizophrenia.
    Hegde S; Thirthalli J; Rao SL; Raguram A; Philip M; Gangadhar BN
    Asian J Psychiatr; 2013 Dec; 6(6):537-43. PubMed ID: 24309868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motivational impairment predicts functional remission in first-episode psychosis: 3-Year follow-up of the randomized controlled trial on extended early intervention.
    Chang WC; Kwong VWY; Or Chi Fai P; Lau ESK; Chan GHK; Jim OTT; Hui CLM; Chan SKW; Lee EHM; Chen EYH
    Aust N Z J Psychiatry; 2018 Dec; 52(12):1194-1201. PubMed ID: 29475381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome.
    Fervaha G; Foussias G; Agid O; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):9-16. PubMed ID: 25982811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study.
    Giordano GM; Koenig T; Mucci A; Vignapiano A; Amodio A; Di Lorenzo G; Siracusano A; Bellomo A; Altamura M; Monteleone P; Pompili M; Galderisi S; Maj M;
    Neuroimage Clin; 2018; 20():627-636. PubMed ID: 30202724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and longitudinal course of cognitive functioning in schizophrenia spectrum disorders, 10years after baseline: The OPUS study.
    Bergh S; Hjorthøj C; Sørensen HJ; Fagerlund B; Austin S; Secher RG; Jepsen JR; Nordentoft M
    Schizophr Res; 2016 Aug; 175(1-3):57-63. PubMed ID: 27050475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cognitive, affective motivational and clinical longitudinal determinants of apathy in schizophrenia.
    Raffard S; Bortolon C; Yazbek H; Lançon C; Benoit M; Norton J; Capdevielle D
    Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):911-920. PubMed ID: 29948250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive Emotions Program for Schizophrenia (PEPS): a pilot intervention to reduce anhedonia and apathy.
    Favrod J; Nguyen A; Fankhauser C; Ismailaj A; Hasler JD; Ringuet A; Rexhaj S; Bonsack C
    BMC Psychiatry; 2015 Sep; 15():231. PubMed ID: 26419356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year clinical and functional outcome comparison between first-episode mania with psychotic features and first-episode schizophrenia.
    Chang WC; Lau ES; Chiu SS; Hui CL; Chan SK; Lee EH; Chen EY
    J Affect Disord; 2016 Aug; 200():1-5. PubMed ID: 27107261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.
    Mezquida G; Cabrera B; Bioque M; Amoretti S; Lobo A; González-Pinto A; Espliego A; Corripio I; Vieta E; Castro-Fornieles J; Bergé D; Escartí MJ; Ibañez Á; Penadés R; Sánchez-Torres AM; Bernardo M;
    Schizophr Res; 2017 Nov; 189():84-90. PubMed ID: 28185786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent negative symptoms after first episode schizophrenia: A 2-year follow-up study.
    Üçok A; Ergül C
    Schizophr Res; 2014 Sep; 158(1-3):241-6. PubMed ID: 25107850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How far to go in deconstructing negative symptoms? Behavioural and neural level evidence for the amotivation domain.
    Kaliuzhna M; Kirschner M; Carruzzo F; Hartmann-Riemer MN; Bischof M; Seifritz E; Tobler PN; Kaiser S
    Schizophr Res; 2021 Oct; 236():41-47. PubMed ID: 34390980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.